Patents by Inventor Noriyasu Hirasawa

Noriyasu Hirasawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR COVID-19
    Publication number: 20230390235
    Abstract: The present invention aims to develop a method for treating COVID-19 caused by SARS-CoV-2 or a mutant strain thereof, and provides an agent for preventing and/or treating COVID-19 caused by SARS-CoV-2 or a mutant strain thereof, the agent comprising a specific compound.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Applicants: SENJU PHARMACEUTICAL CO., LTD., TOHOKU UNIVERSITY
    Inventors: Mitsuyoshi AZUMA, Chiho FUKIAGE, Takashi IMADA, Yayoi KISHIMOTO, Noriyasu HIRASAWA, Yoshiro SAITO, Takashi TOYAMA
  • ANTIALLERGIC AGENT
    Publication number: 20170304236
    Abstract: An object to be achieved by the present invention is to provide a novel antiallergic agent using, as an active ingredient, a compound that has heretofore not been known to have an antiallergic action. The present invention provides an antiallergic agent, including a compound represented by the formula (I) or a salt thereof: where R1 and R2, which are identical to or different from each other, each represent an alkyl group having 1 to 3 carbon atoms, m represents an integer of from 0 to 3, and n represents an integer of from 1 to 3.
    Type: Application
    Filed: March 31, 2016
    Publication date: October 26, 2017
    Applicant: TOHOKU UNIVERSITY
    Inventors: Noriyasu HIRASAWA, Je-Tae WOO, Byung-Yoon CHA, Takayuki YONEZAWA
  • CELL CAPABLE OF EXPRESSING TSLP CONSTANTLY AND AT HIGH LEVEL, AND METHOD FOR SCREENING FOR TSLP MODULATOR UTILIZING THE CELL
    Publication number: 20130096028
    Abstract: The present invention relates to a mouse epithelial cell line constantly producing TSLP and use thereof. More specifically, the present invention relates to a method for screening for a TSLP modulator using a mouse epithelial cell line (KCHM-1) constantly producing TSLP, and a method for producing wild-type TSLP using the cell line.
    Type: Application
    Filed: June 13, 2011
    Publication date: April 18, 2013
    Applicant: TOHOKU UNIVERSITY
    Inventors: Noriyasu Hirasawa, Michihiro Hide